Belite Bio (BLTE) Current Assets (2021 - 2026)

Belite Bio's Current Assets history runs 6 years deep, the most recent figure standing at $521.9 million for Q1 2026.

• On a quarterly basis, Current Assets rose 227.62% year-over-year to $521.9 million in Q1 2026; TTM through Mar 2026 was $521.9 million, a 227.62% increase from a year earlier, with the FY2025 full-year figure at $494.3 million, up 236.07% from the prior year.
• Current Assets climbed to $521.9 million in Q1 2026 per BLTE's latest filing, from $494.3 million in the prior quarter.
• Across five years, Current Assets topped out at $521.9 million in Q1 2026 and bottomed at $38.4 million in Q1 2023.
• The 5-year median for Current Assets is $112.6 million (2024), against an average of $168.5 million.
• Biggest YoY gain for Current Assets was 236.07% in 2025; the steepest drop was 32.59% in 2025.
• Year by year, Current Assets stood at $42.8 million in 2022, then soared by 110.11% to $89.9 million in 2023, then surged by 63.52% to $147.1 million in 2024, then jumped by 236.07% to $494.3 million in 2025, then rose by 5.58% to $521.9 million in 2026.
• Per Business Quant, the three latest BLTE Current Assets figures stand at $521.9 million (Q1 2026), $494.3 million (Q4 2025), and $277.2 million (Q3 2025).